Eskayef Pharmaceuticals Ltd.
| Established | 1990 |
| Market Share | 4.79% |
| Growth | 48.07% |
| Total generics | 443 |
| Headquarter | Plot 82, Road 14, Block B, Banani, Dhaka-1213 |
| Contact details | 880-2-8818327, 8814662 |
| Fax | 880-2-9887373, 9887376 |
Eskayef Bangladesh Limited, a successor of world-renowned multinational pharmaceutical company, SmithKline & French (SK&F), USA was acquired by TRANSCOM Group in 1990. After the acquisition, the new company was named ‘Eskayef Bangladesh Limited’ and it has subsequently culminated to become one of the leading pharmaceutical companies in Bangladesh. Rapid business growth, since its inception has propelled Eskayef to a position of eminence among the pharmaceutical companies operating in Bangladesh today. Owing to its qualified, trained and skilled professionals and through its unswerving standards of quality control, Eskayef is now one of the most respected names in the pharmaceutical industry of Bangladesh.
Mission: To manufacture & supply products with quality and excellency & to contribute to improving the population’s health & well-being.
Vision: To lead the national pharmaceutical market, to be recognized as a multinational conglomerate from Bangladesh and stand out as a model of efficiency & trust to our collaborators, consumers, health care professionals & society.
Mission: To manufacture & supply products with quality and excellency & to contribute to improving the population’s health & well-being.
Vision: To lead the national pharmaceutical market, to be recognized as a multinational conglomerate from Bangladesh and stand out as a model of efficiency & trust to our collaborators, consumers, health care professionals & society.
